- Home
- PKOH vs RNAC Comparison
PKOH vs RNAC Comparison
Compare PKOH & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKOH
- RNAC
- Stock Information
- Founded
- PKOH 1907
- RNAC 2007
- Country
- PKOH United States
- RNAC United States
- Employees
- PKOH N/A
- RNAC N/A
- Industry
- PKOH Industrial Specialties
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- PKOH Industrials
- RNAC Health Care
- Exchange
- PKOH Nasdaq
- RNAC Nasdaq
- Market Cap
- PKOH 282.2M
- RNAC 316.1M
- IPO Year
- PKOH N/A
- RNAC 2016
- Fundamental
- Price
- PKOH $17.49
- RNAC $13.33
- Analyst Decision
- PKOH
- RNAC Strong Buy
- Analyst Count
- PKOH 0
- RNAC 5
- Target Price
- PKOH N/A
- RNAC $40.00
- AVG Volume (30 Days)
- PKOH 38.3K
- RNAC 83.7K
- Earning Date
- PKOH 08-06-2025
- RNAC 08-07-2025
- Dividend Yield
- PKOH 2.86%
- RNAC N/A
- EPS Growth
- PKOH 144.68
- RNAC N/A
- EPS
- PKOH 2.26
- RNAC N/A
- Revenue
- PKOH $1,644,000,000.00
- RNAC $34,173,000.00
- Revenue This Year
- PKOH $1.80
- RNAC N/A
- Revenue Next Year
- PKOH $3.97
- RNAC N/A
- P/E Ratio
- PKOH $5.90
- RNAC N/A
- Revenue Growth
- PKOH N/A
- RNAC 31.91
- 52 Week Low
- PKOH $16.26
- RNAC $8.46
- 52 Week High
- PKOH $34.50
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- PKOH 47.06
- RNAC 60.40
- Support Level
- PKOH $16.26
- RNAC $11.80
- Resistance Level
- PKOH $17.95
- RNAC $13.91
- Average True Range (ATR)
- PKOH 0.84
- RNAC 1.10
- MACD
- PKOH -0.03
- RNAC 0.03
- Stochastic Oscillator
- PKOH 44.73
- RNAC 53.04
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.